Harvard Business Review

SEPTEMBER 4, 2015

We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Pharmaceuticals. The data captured a 20-year period, from 1995 to 2014. Overall, it is a messy picture.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

JANUARY 10, 2013

initiative — prohibitions against off-label marketing under the False Claims Act — swept through the pharmaceutical industry. The most notable was Fannie Mae's $10.8 billion restatement. In another instance, a new enforcement. The largest payments were from Pfizer ($2.3 billion) and GlaxoSmithKline ($3 billion).

Finance 8

Finance Banking Press Release Pharmaceuticals 8

Harvard Business Review

JUNE 9, 2017

Equally troublesome, almost all policies focus exclusively on payments and finances but ignore the powerful influence of careerism and other non-financial motives that may compromise objectivity far more than financial incentives. For academics, publishing and obtaining grants are key to promotion and career advancement.

Conflict of Interest 8

Conflict of Interest Pharmaceuticals Policies Industry 8

Harvard Business Review

APRIL 16, 2012

This raises the question of whether retaining strategic cash makes economic sense and should be viewed as a legitimate corporate finance tool in today's environment. As long as the CFO can stipulate that the company does not intend to repatriate the cash, it avoids the incremental tax that will be levied due to the territorial system of U.S.

Company 13

Company Cost of Capital Finance Long-term 13

Harvard Business Review

OCTOBER 13, 2011

A better understanding of the drivers of behavior is needed for both banks and consumers to understand risk, and for the financial system to provide timely and targeted interventions. The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects.

Banking 10

Banking Pharmaceuticals Microfinance Risk Management 10

Harvard Business Review

OCTOBER 24, 2014

So instead of creating another pill dispenser, it launched a compliance-enhancing system. In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers.

Productivity 8

Productivity Products Company Engineering 8

Harvard Business Review

JANUARY 4, 2017

There are similar stories in the electronics industry, pet food, pharmaceuticals, and even national security. This regulation came as a result of concerns that the exploitation and trade of conflict minerals by armed groups was helping to finance conflict in the DRC region and contributing to its emergency humanitarian crisis.

Supply Chain 8

Supply Chain Productivity Products Company 8

Harvard Business Review

NOVEMBER 20, 2015

One result is that they keep their cards close to their chests about what they are looking for (at first), while expecting you to reveal everything – your finances, pricing, ownership, human resources, production processes, quality assurance, customer service procedures, KPIs, and existing customers.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 19, 2016

Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. Aren’t business managers, or at least those working in the Anglo-American system of capitalism, obligated by law to maximize returns to shareholders? How should you make this decision? But perhaps managers have no choice.

ROI 8

ROI Long-term Conflict of Interest Pharmaceuticals 8

Harvard Business Review

FEBRUARY 23, 2011

The first part of the conference's message, that the infrastructure of the continent is greatly wanting, was a topic of many panels, including a pair of engaging ones on technology, but it was brought home most vividly in another context, by Thierry Tanoh , a vice president at the International Finance Corp.

Conference 12

Conference Pharmaceuticals Politics Entrepreneur 12

Harvard Business Review

JULY 4, 2017

Tim Cook recently confirmed that Apple is working on ‘autonomous systems.’ One way to appeal to this demographic (and to the parents who often finance young drivers’ transportation) is to focus on safety. ’ As usual with Apple, details are sparse, but it’s likely that autonomous cars are part of this.

Transportation 8

Transportation Sports Pharmaceuticals Health Care 8

Harvard Business Review

AUGUST 23, 2012

For highly regulated sectors like finance, social media can be a legal minefield. These hurdles aren't unique to financial services — insurance, pharmaceuticals, health care and government all face regulation, to name a few examples. The best of these systems even come with their own archiving tools already built-in.

Compliance 15

Compliance Media Compliance Officer Policies 15

Harvard Business Review

MAY 1, 2013

Without adequate financing, ministries of health and even private hospitals in developing countries often don''t have the resources needed to purchase diagnostic equipment, train workers, and ensure access to appropriate treatment. Three people die every minute from tuberculosis — a treatable and largely preventable disease.

Health Care 8

Health Care ROI NGO Long-term 8

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Compounding any particular tax issue are requirements for compliance and reporting, which involve activities ranging from country-by-country registrations to continually updated ERP systems.

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

FEBRUARY 4, 2013

How easy is it to change a flawed economic or governance system, such as our current 1.5-planets-and-counting We'd see more corporate social responsibility, socially responsible investing and sustainability reporting, but overall the outcome would be little more than a set of patches on the existing, dysfunctional system.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 5, 2016

Cigna is the first insurance company to get pharmaceutical companies to agree to value pricing based on results for certain cholesterol-lowering drugs. Another problem is that badly designed contracts can leave open the possibility of companies gaming the system. ” Health care.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

AUGUST 23, 2018

For example, Boston’s program includes job placements at private-sector employers across a wide range of industries, including finance, health care, life sciences, and education.

Short-term 8

Short-term Participative Long-term Career 8

Harvard Business Review

NOVEMBER 10, 2017

In one pharmaceutical R&D company, we identified three critical populations that needed to change to enable the execution of the organization’s strategy. Every organization has functions that wield a disproportionate amount of power — the typical suspects are finance, procurement, and audit. Insight center.

Skills 8

Skills Agility Learning-by-Doing Content 8

Harvard Business Review

MAY 15, 2013

This is a problem, because without a reasonable definition (or definitions) of culture, we cannot hope to understand its connections to other key elements of the organization, such as structure and incentive systems. Culture is a social control system. finance vs. marketing) and units (e.g.

Incentives 8

Incentives Definition Pharmaceuticals System 8

Harvard Business Review

MAY 5, 2016

sanctions are delaying these projects being financed. financial system for bank transactions related to Iran. And Danish pharmaceutical company Novo Nordisk is building on its Iran presence by doubling local staff to nearly 300 and investing $76 million in a new factory. However, remaining U.S. Accessing foreign exchange.

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

AUGUST 23, 2016

Both Republicans and Democrats say the most effective board committee is audit/finance. The industry breakout was done using eight major sectors (similar to those in the Global Industry Classification Standard system): Consumer Discretionary (e.g., banking & financial services, insurance, real estate); Healthcare (e.g.,

Politics 8

Politics Committee Telecommunications Diversity 8

Harvard Business Review

SEPTEMBER 13, 2011

Here are some common examples: When pharmaceutical companies announce that a new drug has been "approved," they are actually saying that their researchers made some breakthrough discoveries as far back as fifteen years ago. She also found that some sales teams were able to hit their numbers despite these factors.

Short-term 14

Short-term Pharmaceuticals Long-term Maturity 14

Harvard Business Review

MARCH 6, 2014

Indeed, should this have not crossed your mind, the PLoS authors tie their findings to past behavior by the tobacco and pharmaceutical industries. Like a malign butterfly flapping its wings furiously, the storm damage that a biased finding can do in a dynamic system of knowledge is considerable. Communication'

Peer Review 8

Peer Review Review Industry Wilde 8